HomeCompareCFEIY vs CL

CFEIY vs CL: Dividend Comparison 2026

CFEIY yields 6.41% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CL wins by $17.8K in total portfolio value· pulled ahead in Year 3
10 years
CFEIY
CFEIY
● Live price
6.41%
Share price
$4.99
Annual div
$0.32
5Y div CAGR
-22.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.0K
Annual income
$56.31
Full CFEIY calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — CFEIY vs CL

📍 CL pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCFEIYCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CFEIY + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CFEIY pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CFEIY
Annual income on $10K today (after 15% tax)
$545.09/yr
After 10yr DRIP, annual income (after tax)
$47.86/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, CL beats the other by $4,543.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CFEIY + CL for your $10,000?

CFEIY: 50%CL: 50%
100% CL50/50100% CFEIY
Portfolio after 10yr
$31.9K
Annual income
$2,729.14/yr
Blended yield
8.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

CFEIY
No analyst data
Altman Z
4.7
Piotroski
7/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CFEIY buys
0
CL buys
0
No recent congressional trades found for CFEIY or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCFEIYCL
Forward yield6.41%2.43%
Annual dividend / share$0.32$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-22.8%28.6%
Portfolio after 10y$23.0K$40.8K
Annual income after 10y$56.31$5,401.96
Total dividends collected$2.2K$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CFEIY vs CL ($10,000, DRIP)

YearCFEIY PortfolioCFEIY Income/yrCL PortfolioCL Income/yrGap
1$11,195$495.07$11,012$312.01+$183.00CFEIY
2$12,379$399.88$12,196$412.95+$183.00CFEIY
3← crossover$13,564$319.01$13,599$549.66$35.00CL
4$14,766$252.21$15,288$736.64$522.00CL
5$15,998$198.09$17,353$995.28$1.4KCL
6$17,272$154.84$19,926$1,357.80$2.7KCL
7$18,602$120.62$23,194$1,873.82$4.6KCL
8$19,998$93.73$27,439$2,621.52$7.4KCL
9$21,470$72.70$33,088$3,727.38$11.6KCL
10$23,029$56.31$40,806$5,401.96$17.8KCL

CFEIY vs CL: Complete Analysis 2026

CFEIYStock

China Feihe Limited, an investment holding company, produces and sells infant milk formula products in Mainland China and the United States. The company offers a range of raw milk, adult milk powders, liquid milk products and health care products, as well as soybean powder and goat milk powder. It is also involved in the retail of vitamins, minerals, herbs, and other nutritional supplements. The company sells its products through distributors; and e-commerce platforms, such as Tmall, JD.com, and Suning.com, as well as through its website and mobile application, including WeChat. As of December 31, 2021, it operated a distribution network of approximately 2,000 offline customers with 110,000 retail points of sale. China Feihe Limited was founded in 1962 and is headquartered in Beijing, the People's Republic of China.

Full CFEIY Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this CFEIY vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CFEIY vs SCHDCFEIY vs JEPICFEIY vs OCFEIY vs KOCFEIY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.